Jesus A. Araujo, MD, MSc, PhD

Jesus A. Araujo, MD, PhD

Associate Professor, Department of Medicine, Cardiology
Director of Environmental Cardiology

Languages

English, Spanish

Specialty

Internal Medicine, Cardiology

Institutional Affiliation

Ronald Reagan UCLA Medical Center

Education

Fellowship

Cardiovascular Disease, UCLA School of Medicine, 1998 - 2003

Internship

Internal Medicine, Beth Israel Medical Center, 1994 - 1995

Degrees

PhD, Molecular Biology, Molecular Biology Institute, UCLA, 2004
MD, Universidad Central de Venezuela, 1991

Residency

Internal Medicine, Beth Israel Medical Center, 1995 - 1998

Board Certifications

Echocardiography, National Board of Echocardiography, 2004
Internal Medicine, American Board of Internal Medicine, 1997

Clinical Interests

General Cardiology, Echocardiography

Scientific Interests

Dr. Jesus Araujo's research interests are focused on dissecting mechanisms, molecular pathways and gene-environment interactions of relevance in the induction of cardiopulmonary effects by air pollutants. His Environmental Cardiology and Vascular Biology Laboratory is studying how air particulate matter (PM) promotes atherosclerosis and ischemic heart disease, likely via the promotion of systemic prooxidative and proinflammatory effects that may occur as a consequence of similar effects in the Lungs. Dr. Araujo is also interested to determine how PM-induced pro-oxidative and pro-inflammatory effects in the lungs may lead to DNA damage and pro-oncogenic effects, which appear to be similar to effects caused by passive cigarette smoking.

Highlighted Publications

Hickey MJ, Malone CC, Erickson KE, Gomez GG, Young EL, Liau LM, Prins RM, Kruse CA. Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas. Am J Transl Res. 2012;4(1):114-26. Epub 2012 Jan 10.

Ma W, Chen M, McElroy M, Zhang Y, Ozkan C, Bouvet M, Kruse CA, Grotjahn D, Ichim T, Minev B. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. Intl. J. Nanomed. 2012 7, 1475-1487.

Hickey MJ, Malone CC, Erickson KL, Jadus MR, Prins RM, Liau LM, Kruse CA. Cellular and vaccine therapeutic approaches for gliomas. J Transl Med. 2010 Oct 14;8:100.

Hickey MJ, Malone CC, Erickson KL, Jadus MR, Prins RM, Liau LM, Kruse CA.Cellular and vaccine therapeutic approaches for gliomas. J Transl Med. 2010 Oct 14;8:100.

Gomez GG, Hickey MJ, Tritz R, Kruse CA. Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors. Gene Ther Mol Biol. 2008 Jun;12(1):101-110.